Guide to Drug Financing Mechanisms
(1998; 64 pages) [French] [Spanish]
Table of Contents
View the documentForeword
View the documentAcknowledgements
Open this folder and view contentsIntroduction
Open this folder and view contentsChapter 1. Selection
Open this folder and view contentsChapter 2. Procurement
Close this folderChapter 3. Distribution
Close this folderObjective of distribution
View the documentGeographical access
View the documentPhysical access
View the documentEconomic access
Open this folder and view contentsImproving distribution
Open this folder and view contentsFinancing of consumption
Open this folder and view contentsChapter 4. Prescribing
Open this folder and view contentsSummary: contributions and limitations of the economic approach
View the documentReferences
View the documentSelected WHO publications of related interest
View the documentBack cover
 

Physical access

Physical access refers to the availability of stocks of drugs normally present in a pharmacy (and hence authorized for distribution at that pharmacy). In many developing countries, depletion of drug inventory threatens the continuity of care and the usefulness of the health services.

Table 9. Number of localities with a health service having a pharmacy (example)

Type of health service

Total

With pharmacy

Without pharmacy

Hospital

50

50

0

Health centre

75

15

60

Dispensary

200

20

180

Total

325

85

240

Table 10. Average availability of two drugs at health centres in Rwanda

Indicator

Private sector
n = 20

Public sector

   

A
n = 20

B*
n = 20

Number of drugs stocked

81

35

48

Average number of days
per month depleted stock

     
 

Penicillin

0

8.7

5.0

 

Antimalarials

0

4.0

3.8

Source: Habiyambere (15)

* Centres in public sector B participate in a drugs supply programme not available to the other sectors

In order to prevent shortages of stock, the duration of these shortages must first be measured. Shortages of stock may be measured in terms of the proportion of days (or weeks) that drugs are not on the shelves during the period considered (a month or a year). Table 10 provides an example. One must first know what drugs are supposed to be available. Then, stock management records or spot checks permit calculation of the number of days that certain drugs are out of stock during a given month. Without this information it is not possible to know whether reorganization has reduced stock shortages. Progress needs to be monitored very closely.

When information is plentiful, stock shortages that are calculated for individual drugs can be grouped to derive figures for classes of drugs. The mean duration of shortages of all vital, essential or non-essential drugs in terms of the VEN classification can be calculated.

to previous section to next section
 

Last updated: May 3, 2013